
Opinion|Videos|August 15, 2024
Topical Ruxolitinib in Vitiligo: Real-World Experiences and Cultural Considerations
Author(s)Chesahna Kindred, MD, MBA, FAAD
Chesahna Kindred, MD, discusses real-world experiences and cultural considerations associated with topical ruxolitinib for the treatment of vitiligo.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Dermalogica Enters Medical Aesthetics with FDA-Cleared Microneedling PRO Pen
2
Social Media Mythbusters: Hypochlorous Acid Sprays
3
Quoin Submits First-Ever IND Application for Peeling Skin Syndrome Therapy
4
SkinJect Advances into Registrable Development as Potential First-in-Class Therapy for Gorlin Syndrome
5














